 |
 |
 |
|
SIMULATED PHARMACOKINETIC INTERACTIONS OF
RIFAMPICIN WITH RITONAVIR-BOOSTED DARUNAVIR
|
|
|
Reported by Jules Levin
19th International Workshop on Clinical Pharmacology of Antiviral Therapy, 22 -24 May 2018, Baltimore, Maryland, USA
Frank Jacobs1, Yvonne Van Delft2, Herta Crauwels1,4, Sophie Lachau-Durand1, Perry Mohammed3, Mario Monshouwer1and Jan Snoeys1
1Janssen Research and Development, Beerse, Belgium; 2Janssen-Cilag BV, Tilburg, The Netherlands; 3Janssen Ltd, High-Wycombe, United Kingdom; 4Presenting author






|
|
|
 |
 |
|
|